Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34057795)
Watch
English
Peptide analogs in the therapy of prostate cancer.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Peptide analogs in the therapy of prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author
Andrew Schally
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
author name string
A M Comaru-Schally
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
A Plonowski
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
A Nagy
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
G Halmos
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
Z Rekasi
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
publication date
1 October 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
published in
The Prostate
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
volume
45
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
page(s)
158-166
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
cites work
Future prospects in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Cancer statistics, 2000.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Evaluation and management of the man who has failed primary curative therapy for prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Hormone-refractory (D3) prostate cancer: refining the concept.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Synthesis and biological activity of highly potent octapeptide analogs of somatostatin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F1097-0045%2820001001%2945%3A2%3C158%3A%3AAID-PROS10%3E3.0.CO%3B2-K
retrieved
21 January 2018
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers
0 references
Bombesin stimulates growth of human prostatic cancer cells in vitro
0 references
Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents
0 references
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors
0 references
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice
0 references
Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
0 references
Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers
0 references
High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers
0 references
The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer
0 references
MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS
0 references
Identifiers
DOI
10.1002/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO;2-K
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
PubMed ID
11027415
1 reference
stated in
Europe PubMed Central
PubMed ID
11027415
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11027415%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
